Piper Sandler raised the firm’s price target on Guardant Health (GH) to $120 from $90 following quarterly results. The firm keeps an Overweight rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GH:
- Guardant Health Completes $402.5M Convertible Notes Offering
- Cathie Wood Buys the Dip in Pinterest (PINS), Sells Roku and Robinhood Stocks
- Guardant Health announces Shield blood-based screening test results
- Guardant Health 3.33M share Spot Secondary priced at $90.00
- Guardant Health announces $250M common stock offering